Navigation Links
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Date:9/30/2010

results of SORT-OUT IV, comparing Cordis Corporation's CYPHER(R) Sirolimus-eluting Coronary Stent and Abbott's XIENCE V (R) Everolimus-eluting Stent in the primary endpoint of MACE (major acute coronary events) at nine months. These findings were presented the week commencing 20th September 2010 at the TCT Congress, one of the largest cardiovascular industry events held annually in Washington DC. This study adds to the unmatched body of clinical safety and efficacy data on the CYPHER(R) Stent with this comparison to the more recently approved XIENCE V(R) Stent in a contemporary setting.

"The SORT OUT consortium has used CYPHER(R) Stent as the comparator in a number of studies and to date, no newer stent has proven a benefit over CYPHER(R) Stent in terms of clinical safety or efficacy," said Campbell Rogers, M.D., Chief Scientific Officer and Head, Global Research and Development, Cordis Corporation. "The clinical safety and efficacy of the CYPHER(R) Stent in this real-world randomized study reinforce the excellent sustained clinical outcomes consistently seen over the last 10 years."

The large randomized trial SORT OUT IV included more than 2,600 patients across a wide range of lesion and patient complexity. The study was designed to test whether the XIENCE V(R) stent is non-inferior to the CYPHER(R) Stent. Both drug-eluting stents performed better than planned for the composite endpoint of MACE (4.9 % for XIENCE V(R) Stent vs. 5.2% for CYPHER(R) Stent); these data support the non-inferiority of the XIENCE V(R) stent over the CYPHER(R) stent (non-inferiority p=0.01) . There was no statistically significant difference in key markers of safety including the incidence of cardiac death (1.9% for XIENCE V(R) Stent vs. 1.4% for CYPHER(R) Stent: p=0.31), myocardial infarction, (1.1% for XIENCE V(R) Stent vs. 1.4% for CYPHER(R) Stent: p=0.48), or definite or probable stent thrombosis (0.9% for XIENCE V(R) Stent vs. 0.9% for CYPHER(R) Stent: p=0.83).


'/>"/>

SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
2. Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
3. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
6. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
7. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
8. Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeichs Combo™ Bio-engineered Sirolimus Eluting Stent
9. Pre-clinical Data Show OrbusNeichs Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies
10. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
11. MacuSight(TM) Announces Positive Initial Results From Phase 1 Study of Sirolimus in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Mass. , Aug. 29, ... PHG AEX: ... the  European Society of Cardiology ... is highlighting the full range of its cardiology solutions serving ... care continuum from prevention and diagnosis, ...
(Date:8/28/2014)... -- Reportlinker.com announces that a new market research ... North America Aesthetic Lasers and Energy Devices Market ... North America Aesthetic Lasers and ... GlobalData,s new report, "North America Aesthetic Lasers ... key market data on the North America Aesthetic ...
(Date:8/28/2014)... Long, P.A.: , Do you, or did you, ... , Did you purchase your shares before September 10, 2013, ... , Did you lose money in your investment in Lannett ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
Breaking Medicine Technology:Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3
... ReSearch Pharmaceutical Services, Inc. ("RPS" or the "Company"), ... to the bio-pharmaceutical industry, is pleased to announce its ... September 30, 2009. These statements include unaudited comparative ... ended September 30, 2008. , In addition, RPS announces ...
... 13 /PRNewswire/ Millar Instruments, Inc., developer and manufacturer ... systems, and Transonic Systems, Inc., global leader in ... devices, today announce a new distribution partnership. , ... in the field of physiological measurements, Transonic Systems ...
Cached Medicine Technology:ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 2ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 3ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 4ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 5ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 6ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 7ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 8ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 9ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 10ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009 11Millar Instruments and Transonic Systems, Suppliers of Gold Standard Pressure and Flow Products, Enter Into Mutual Distribution Agreement 2
(Date:8/29/2014)... 2014 According to Macmillan Cancer Support ... conference held in Birmingham, England last June, “More than ... disease recur”. This only goes to show how tremendously ... struggling to fight its grueling series of treatments. In ... journey through breast cancer is featured in the compelling ...
(Date:8/29/2014)... August 29, 2014 Today, Fecbek, a well-known ... series of super quality female boots. The new items are ... the knee, and snow boots. All these products are nice-looking ... great discounts to all its clients. , A boot is ... Most boots mainly cover the foot and the ankle and ...
(Date:8/29/2014)... 29, 2014 In short, minimally invasive ... Scott Katzman of Orthopedic and Laser Spine Surgery ... perform repairs. Problems with the discs, nerves and ... number of treatment needs that can be offered from ... an advantageously small incision and intervention that exposes the ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 First Choice ... facility at 7am today. The new facility is located 1501 ... “Our team is pleased to be a part of First ... forward to continuing to deliver high quality emergency medical care ... Director of First Choice Emergency Room Pflugerville – FM 685. ...
(Date:8/29/2014)... Today, Progene reaches another milestone as the only testosterone ... healthcare network , but also with enrolled providers nationwide who ... few weeks ago. Today, we’re now recommended by healthcare ... , The network adds an unprecedented level of service to ... and after they make a purchase -- with the best ...
Breaking Medicine News(10 mins):Health News:Lisa Grimaldi Shares Her Fashionable Journey through Breast Cancer 2Health News:Nice Boots for Sale at Fecbek.com 2Health News:Advancements in Spine Surgery Offered by this Modern Florida Surgery Group are Cutting Out Historically Demanding Recovery Times 2Health News:First Choice Emergency Room Opens New Facility in Pflugerville, Texas 2Health News:Progene Is Doctor Recommended Nationwide 2Health News:Progene Is Doctor Recommended Nationwide 3
... Lake Chamber host roundtable discussion as part of national ... Campaign for an American Solution, ... met with Utah small business owners at a,roundtable discussion on health ... part of the health insurance industry,s Campaign for,an American Solution, a ...
... Aug. 27 The National Labor,Relations Board issued ... from the Easton facility had filed a series ... threatening,retaliating against workers, and attempting to bribe workers ... real improvements. They,re,trying to buy us off by ...
... NEW YORK, Aug. 27 According to the Fluoride,Action ... parties to restore,scientific integrity to the Centers for Disease ... continued unscientific support for,water fluoridation., "The simplest and ... is,for both Democrats and Republicans to put a commitment ...
... 30, ... 2008, COPENHAGEN, August 27 ... June 30, 2008.,During this period, Genmab reported the following results:, Genmab,s revenues ... the same period of 2007, Genmab recognized revenues of DKK,280 million (USD 59 ...
... at Florida Hospital will be Model for Pediatric ... ... from,Florida Hospital today revealed new details about their visionary plans to,shape ... on children,s health throughout Central Florida and be a,model for pediatric ...
... treatment for diabetes , , WEDNESDAY, Aug. 27 (HealthDay News) -- ... into insulin-producing beta cells, a feat they call an "extreme ... treatment or even a cure for both type 1 and ... insulin production or uptake. , The process, reported online Aug. ...
Cached Medicine News:Health News:Health Insurance Industry Listens to Health Care Concerns of Utah Small Business Owners 2Health News:Health Insurance Industry Listens to Health Care Concerns of Utah Small Business Owners 3Health News:Carlyle-ManorCare Facing New Federal Charges for Breaking the Law: Interrogating, Threatening, Retaliating Against Nursing Home Workers for Trying to Form a Union 2Health News:Both Parties Need Planks to Restore Scientific Integrity at the CDC 2Health News:Genmab Announces 2008 First Half Year Results 2Health News:Genmab Announces 2008 First Half Year Results 3Health News:Genmab Announces 2008 First Half Year Results 4Health News:Genmab Announces 2008 First Half Year Results 5Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 2Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 3Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 4Health News:Florida Hospital Unveils New Details, Name for 'Children's Hospital of the Future' 5Health News:Pancreatic Cells Turned Into Insulin-Producing Beta Cells 2Health News:Pancreatic Cells Turned Into Insulin-Producing Beta Cells 3
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
... looking for a traditional ECG ... with electronic storage features, the ... of both worlds. It maintains ... of the Atria 3000 and ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: